PRKCA and metabolic dysfunction-associated steatotic liver disease: Sema7aR145W (SEMA7AR148W) binds to integrin β1 to induce the phosphorylation of PKCα and activation of downstream signals, contributing to intrahepatic lipid accumulation and aggravating NAFLD [9].